The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets
Open accessAbstract
Peripheral T cell lymphoma, unspecified (PTCL/U), the most common form of PTCL, displays heterogeneous morphology and phenotype, poor response to treatment, and poor prognosis. We demonstrate that PTCL/U shows a gene expression profile clearly distinct from that of normal T cells. Comparison with the profiles of purified T cell subpopulations (CD4+, CD8+, resting [HLA-DR-], and activated [HLA-DR+]) reveals that PTCLs/U are most closely related to activated peripheral T lymphocytes, either CD4+ or CD8+. Interestingly, the global gene expression profile cannot be surrogated by routine CD4/CD8 immunohistochemistry. When compared with normal T cells, PTCLs/U display deregulation of functional programs often involved in tumorigenesis (e.g., apoptosis, proliferation, cell adhesion, and matrix remodeling). Products of deregulated genes can be detected in PTCLs/U by immunohistochemistry with an ectopic, paraphysiologic, or stromal location. PTCLs/U aberrantly express, among others, PDGFRalpha, a tyrosine-kinase receptor, whose deregulation is often related to a malignant phenotype. Notably, both phosphorylation of PDGFRalpha and sensitivity of cultured PTCL cells to imatinib (as well as to an inhibitor of histone deacetylase) were found. These results, which might be extended to other more rare PTCL categories, provide insight into tumor pathogenesis and clinical management of PTCL/U.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Harris, N., Jaffe, E., Stein, H., Banks, P., Chan, J., Cleary, M., Delsol, G., De Wolf- Peeters, C., Falini, B., & Gatter, K. (1994) · Blood · doi:10.1182/blood.v84.5.1361.1361 · Cited by 6,327
(1975) · CERN Document Server (European Organization for Nuclear Research) · Cited by 5,958
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
Heldin, C.-H., & Westermark, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1283 · Cited by 2,496
The Non-Hodgkin's Lymphoma Classification Project (1997) · Blood · doi:10.1182/blood.v89.11.3909 · Cited by 2,461
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
Heinrich, M. C., Corless, C. L., Demetri, G. D., Blanke, C. D., von Mehren, M., Joensuu, H., McGreevey, L. S., Chen, C.-J., Van den Abbeele, A. D., Druker, B. J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.190 · Cited by 2,299
Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues
Jaffe, E. S. (2003) · Cited by 2,141
Identifying biological themes within lists of genes with EASE
Hosack, D. A., Dennis, G., Sherman, B. T., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-10-r70 · Cited by 1,950
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
Ferrando, A. A., Neuberg, D. S., Staunton, J., Loh, M. L., Huard, C., Raimondi, S. C., Behm, F. G., Pui, C.-H., Downing, J. R., Gilliland, D. G., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00018-1 · Cited by 1,131
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues
Liu, C.-G., Calin, G. A., Meloon, B., Gamliel, N., Sevignani, C., Ferracin, M., Dumitru, C. D., Shimizu, M., Zupo, S., Dono, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403293101 · Cited by 948
Self-citationKlein, U., Tu, Y., Stolovitzky, G. A., Mattioli, M., Cattoretti, G., Husson, H., Freedman, A., Inghirami, G., Cro, L., Baldini, L., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.11.1625 · Cited by 918
Self-citationA literature network of human genes for high-throughput analysis of gene expression
Jenssen, T.-K., Lægreid, A., Komorowski, J., & Hovig, E. J. (2001) · Nature Genetics · doi:10.1038/88213 · Cited by 839
Brodie, S. E. (1996) · Survey of Ophthalmology · doi:10.1016/s0039-6257(96)80075-0 · Cited by 745
Chtanova, T., Tangye, S. G., Newton, R., Frank, N., Hodge, M. R., Rolph, M. S., & Mackay, C. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.68 · Cited by 722
Gallamini, A. (2004) · Blood · doi:10.1182/blood-2003-09-3080 · Cited by 598
Peng, B., Hayes, M., Resta, D., Racine-Poon, A., Druker, B. J., Talpaz, M., Sawyers, C. L., Rosamilia, M., Ford, J., Lloyd, P., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.050 · Cited by 472
Sabattini, E., Bisgaard, K., Ascani, S., Poggi, S., Piccioli, M., Ceccarelli, C., Pieri, F., Fraternali-Orcioni, G., & Pileri, S. A. (1998) · Journal of Clinical Pathology · doi:10.1136/jcp.51.7.506 · Cited by 461
Self-citationPiekarz, R. L., Robey, R., Sandor, V., Bakke, S., Wilson, W. H., Dahmoush, L., Kingma, D. M., Turner, M. L., Altemus, R., & Bates, S. E. (2001) · Blood · doi:10.1182/blood.v98.9.2865 · Cited by 445
Gisselbrecht, C., Gaulard, P., Lepage, É., Coiffier, B., Brière, J., Haïoun, C., Cazals-Hatem, D. L., Bosly, A., Xerri, L., Tilly, H., et al. (1998) · PubMed · doi:10.1182/blood.v92.1.76.413a19_76_82 · Cited by 437
Suchi, T., Lennert, K., Tu, L. Y., Kikuchi, M., Sato, E., Stansfeld, A. G., & Feller, A. C. (1987) · Journal of Clinical Pathology · doi:10.1136/jcp.40.9.995 · Cited by 402
Fredersdorf, S., Burns, J., Milne, A. M., Packham, G., Fallis, L., Gillett, C. E., Royds, J. A., Peston, D., Hall, P. A., Hanby, A. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6380 · Cited by 357
Antigen retrieval techniques in immunohistochemistry: comparison of different methods
Pileri, S. A., Roncador, G., Ceccarelli, C., Piccioli, M., Briskomatis, A., Sabattini, E., Ascani, S., Santini, D., Piccaluga, P. P., Leone, O., et al. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199709)183:1<116::aid-path1087>3.0.co;2-2 · Cited by 338
Self-citationGadd45β mediates the NF-κB suppression of JNK signalling by targeting MKK7/JNKK2
Papa, S., Zazzeroni, F., Bubici, C., Jayawardena, S., Alvarez, K., Matsuda, S., Nguyen, D. U., Pham, C. G., Nelsbach, A. H., Melis, T., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1093 · Cited by 321
van den Boom, J., Wolter, M., Kuick, R., Misek, D. E., Youkilis, A. S., Wechsler, D. S., Sommer, C., Reifenberger, G., & Hanash, S. M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63463-3 · Cited by 307
Gotlib, J., Cools, J., Malone, J. M., Schrier, S. L., Gilliland, D. G., & Coutré, S. E. (2004) · Blood · doi:10.1182/blood-2003-06-1824 · Cited by 290
Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders
Pardanani, A., Reeder, T., Porrata, L. F., Li, C.-Y., Tazelaar, H. D., Baxter, E. J., Witzig, T. E., Cross, N. C. P., & Tefferi, A. (2003) · Blood · doi:10.1182/blood-2002-10-3103 · Cited by 227
Rizvi, M. A., Evens, A. M., Tallman, M. S., Nelson, B. P., & Rosen, S. T. (2006) · Blood · doi:10.1182/blood-2005-03-1306 · Cited by 223
Jin, S., Tong, T., Fan, W., Fan, F., Antinore, M. J., Zhu, X., Mazzacurati, L., Li, X., Petrik, K. L., Rajasekaran, B., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1206034 · Cited by 207
Basso, K., Liso, A., Tiacci, E., Benedetti, R., Pulsoni, A., Foa, R., Di Raimondo, F., Ambrosetti, A., Califano, A., Klein, U., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031175 · Cited by 206
Self-citationLin, M.-T., Chang, C.-C., Chen, S.-T., Chang, H.-L., Su, J.-L., Chau, Y.-P., & Kuo, M.-L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402305200 · Cited by 194
Cyr61 promotes breast tumorigenesis and cancer progression
Tsai, M.-S., Bogart, D. F., Castañeda, J. M., Li, P., & Lupu, R. (2002) · Oncogene · doi:10.1038/sj.onc.1205682 · Cited by 189
Nagashima, M., Shiseki, M., Pedeux, R., Okamura, S., Kitahama-Shiseki, M., Miura, K., Yokota, J., & Harris, C. C. (2003) · Oncogene · doi:10.1038/sj.onc.1206115 · Cited by 189
Analysis of gene expression microarrays for phenotype classification.
Califano, A., Stolovitzky, G. A., & Tu, Y. (2000) · PubMed · Cited by 184
Self-citationBCL10 Expression in Normal and Neoplastic Lymphoid Tissue
Ye, H., Doǧan, A., Karran, L., Willis, T. G., Chen, L., Włodarska, I., Dyer, M. J. S., Isaacson, P. G., & Du, M. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64630-5 · Cited by 182
Xie, D., Yin, D., Wang, H.-J., Liu, G.-T., Elashoff, R., Black, K., & Koeffler, H. P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0659-03 · Cited by 179
Tracey, L., Villuendas, R., Dotor, A. M., Spiteri, I., Ortiz, P., García, J. F., Peralto, J. L. R., Lawler, M., & Piris, M. A. (2003) · Blood · doi:10.1182/blood-2002-11-3574 · Cited by 166
Tan, K. O., Tan, K. M. L., Chan, S. L., Yee, K. S. Y., Bévort, M., Ang, K. C., & Yu, V. C. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008955200 · Cited by 155
Kadin, M. E., Berard, C. W., Nanba, K., & Wakasa, H. (1983) · Human Pathology · doi:10.1016/s0046-8177(83)80299-8 · Cited by 144
Changes in gene expression during progression of ovarian carcinoma
Tapper, J., Kettunen, E., El-Rifai, W. M., Seppälä, M. T., Andersson, L. C., & Knuutila, S. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(01)00386-7 · Cited by 141
Sado, Y., Kagawa, M., Naito, I., Ueki, Y., Seki, T., Momota, R., Oohashi, T., & Ninomiya, Y. (1998) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022003 · Cited by 140
Imatinib targets other than bcr/abl and their clinical relevance in myeloid disorders
Pardanani, A. D., & Tefferi, A. (2004) · Blood · doi:10.1182/blood-2004-01-0246 · Cited by 137
Ascani, S., Zinzani, P. L., Gherlinzoni, F., Sabattini, E., Briskomatis, A., Vivo, A. D., Piccioli, M., Orcioni, G. F., Pieri, F., Goldoni, A., et al. (1997) · Annals of Oncology · doi:10.1023/a:1008200307625 · Cited by 136
Self-citationTsai, M.-S., Hornby, A. E., Lakins, J. N., & Lupu, R. (2000) · PubMed · Cited by 132
Gündüz, M., Ouchida, M., Fukushima, K., Ito, S., Jitsumori, Y., Nakashima, T., Nagai, N., Nishizaki, K., & Shimizu, K. (2002) · Oncogene · doi:10.1038/sj.onc.1205540 · Cited by 132
Identification of a novel integrin α6β1 binding site in the angiogenic Inducer CCN1 (CYR61)
Leu, S.-J., Liu, Y., Chen, N., Chen, C.-C., Lam, S. C.-T., & Lau, L. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305862200 · Cited by 131
Chtanova, T., Newton, R. A., Liu, S. M., Weininger, L., Young, T. R., Silva, D. G., Bertoni, F., Rinaldi, A., Chappaz, S., Sallusto, F., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.7837 · Cited by 131
Hirose, T., Sowa, Y., Takahashi, S., Saito, S., Yasuda, C., Shindo, N., Furuichi, K., & Sakai, T. (2003) · Oncogene · doi:10.1038/sj.onc.1207091 · Cited by 128
Greiner, T. C., Raffeld, M. A., Lutz, C. T., Dick, F. R., & Jaffe, E. S. (1995) · Europe PMC (PubMed Central) · Cited by 122
Gu, J., Fujibayashi, A., Yamada, K. M., & Sekiguchi, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200383200 · Cited by 120
Differential expression of NF-κB pathway genes among peripheral T-cell lymphomas
Martínez–Delgado, B., Cuadros, M., Honrado, E., de la Parte, A. R., Roncador, G., Alves, J., Castrillo, J. M., Rivas, C., Benitez, J. J., & and The Spanish Cooperative Group for the study of T-cell lymphomas (2005) · Leukemia · doi:10.1038/sj.leu.2403960 · Cited by 112
Gene expression profiles during human CD4+ T cell differentiation
Lee, M. S., Hanspers, K., Barker, C. S., Korn, A. P., & McCune, J. M. (2004) · International Immunology · doi:10.1093/intimm/dxh112 · Cited by 107
Opposite Effect of NF-κB and c-Jun N-terminal Kinase on p53-independent GADD45 Induction by Arsenite
Chen, F., Lu, Y., Zhang, Z., Vallyathan, V., Ding, M., Castranova, V., & Shi, X. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011682200 · Cited by 101
Mahadevan, D., Spier, C. M., Croce, K. D., Miller, S. J., George, B. L., Riley, C., Warner, S. H., Grogan, T. M., & Miller, T. P. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0146 · Cited by 99
Martínez–Delgado, B., Meléndez, B., Cuadros, M., Álvarez, J., Castrillo, J. M., de la Parte, A. R., Mollejo, M., Bellas, C., Díaz‐Uriarte, R., Lombardía, L., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0269 · Cited by 95
Regulation of Cyr61 gene expression by mechanical stretch through multiple signaling pathways
Tamura, I., Rosenbloom, J., Macarak, E., & Chaqour, B. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.281.5.c1524 · Cited by 90
Kassem, H. S., Sangar, V., Cowan, R. A., Clarke, N. W., & Margison, G. P. (2002) · International Journal of Cancer · doi:10.1002/ijc.10631 · Cited by 88
Regulation of Cyr61/CCN1 gene expression through RhoA GTPase and p38MAPK signaling pathways
Han, J., Macarak, E. J., Rosenbloom, J., Chung, K. C., & Chaqour, B. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03723.x · Cited by 82
Antileukemia activity of the combination of an anthracycline with a histone deacetylase inhibitor
Sánchez‐González, B., Yang, H., Bueso-Ramos, C., Hoshino, K., Quintás‐Cardama, A., Richon, V. M., & Garcia‐Manero, G. (2006) · Blood · doi:10.1182/blood-2005-09-008086 · Cited by 79
Distribution of IGFBP-rP1 in Normal Human Tissues
Degeorges, A., Wang, F., Frierson, H. F., Seth, A. K., & Sikes, R. A. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800603 · Cited by 79
Targeting Pdgf Receptors in Cancer Rationales and Proof of Concept Clinical Trials
George, D. J. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0081-0_12 · Cited by 77
Schober, J. M., Lau, L. F., Ugarova, T. P., & Lam, S. C.-T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301534200 · Cited by 76
The FIP1L1-PDGFR?? kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia
Cools, J., Stover, E. H., Włodarska, I., Marynen, P., & Gilliland, D. G. (2003) · Current Opinion in Hematology · doi:10.1097/00062752-200401000-00008 · Cited by 75
Peripheral T-Cell Lymphoma Complicated by a Proliferation of Large B Cells
Higgins, J., van de Rijn, M., Jones, C. D., Zehnder, J. L., & Warnke, R. A. (2000) · American Journal of Clinical Pathology · doi:10.1309/72cm-kaxf-66de-4xva · Cited by 71
Xu, J., Capezzone, M., Xu, X. L., & Hershman, J. M. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0215 · Cited by 65
Savarese, T. M., Campbell, C. L., McQuain, C., Mitchell, K., Guardiani, R., Quesenberry, P. J., & Nelson, B. E. (2002) · Cytokine · doi:10.1006/cyto.2002.1022 · Cited by 61
Zheng, P., Sieuwerts, A. M., Luider, T. M., van der Weiden, M., Smitt, P. A. E. S., & Kros, J. M. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63778-9 · Cited by 58
Imatinib Mesylate Inhibits Leydig Cell Tumor Growth: Evidence for In vitro and In vivo Activity
Basciani, S., Brama, M., Mariani, S., Luca, G. D., Arizzi, M., Vesci, L., Pisano, C., Dolci, S., Spera, G., & Gnessi, L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2181 · Cited by 45
Jones, D., Fletcher, C. D. �., Pulford, K. A. F., Shahsafaei, A., & Dorfman, D. M. (1999) · Blood · doi:10.1182/blood.v93.10.3487.410k39_3487_3493 · Cited by 43
Brown, R. E., & Nazmi, R. K. (2002) · PubMed · Cited by 21
T-cell activation-associated antigen expression by neoplastic T-cells.
Chadburn, A., Inghirami, G., & Knowles, D. (1992) · PubMed · Cited by 13
Platelet-derived growth factor receptor inhibition to treat idiopathic hypereosinophilic syndrome
Stone, R. M., Gilliland, D. G., & Klion, A. D. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.03.035 · Cited by 12
Cited by
Campo, E., Swerdlow, S. H., Harris, N. L., Pileri, S., Stein, H., & Jaffe, E. S. (2011) · Blood · doi:10.1182/blood-2011-01-293050 · Cited by 2,008
Self-citationThe anaplastic lymphoma kinase in the pathogenesis of cancer
Chiarle, R., Voena, C., Ambrogio, C., Piva, R., & Inghirami, G. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2291 · Cited by 882
Iqbal, J., Wright, G., Wang, C., Rosenwald, A., Gascoyne, R. D., Weisenburger, D. D., Greiner, T. C., Smith, L., Guo, S., Wilcox, R. A., et al. (2014) · Blood · doi:10.1182/blood-2013-11-536359 · Cited by 552
Self-citationMethionine is a metabolic dependency of tumor-initiating cells
Wang, Z., Yip, L. Y., Lee, J. H. J., Wu, Z., Chew, H. Y., Chong, P. K. W., Teo, C. C., Ang, H. Y.-K., Peh, K. L. E., Yuan, J., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0423-5 · Cited by 403
Iqbal, J., Weisenburger, D. D., Greiner, T. C., Vose, J. M., McKeithan, T., Kucuk, C., Geng, H., Deffenbacher, K., Smith, L., Dybkaer, K., et al. (2010) · Blood · doi:10.1182/blood-2009-06-227579 · Cited by 392
Metadata
- Authors
- Piccaluga, P. P., Agostinelli, C., Califano, A., Rossi, M., Basso, K., Zupo, S., Went, P., Klein, U., Zinzani, P. L., Baccarani, M., Dalla Favera, R., & Pileri, S. A.
- Venue
- Journal of Clinical Investigation
- Published
- 2007-03-01
- Volume
- 117
- Issue
- 3
- Pages
- 823-834
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2079116568
- Cited by
- 303
- References
- 72
- FWCI
- 12.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.